Education
About Us
Working with TipRanks
Follow Us
Eric Venker Insider Profile
4 Followers
Eric Venker, President & Immunovant CEO at Roivant Sciences, holds 1.66M shares in Roivant Sciences (Ticker: ROIV), holds ― shares in Immunovant (Ticker: IMVT).
Eric Venker Roivant Sciences (ROIV)President & Immunovant CEO
Roivant Sciences (ROIV)
President & Immunovant CEO
Ranked #85,292 out of 102,971 Corporate Insiders
Profitable Transactions
3 out of 8 Profitable Transactions
Average Return
-18.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Eric Venker holds in companies
Most Profitable Insider Trade
The most profitable trade made by Eric Venker
Eric Venker's Trading History
Roivant Sciences
Aug 01, 2025
President & Immunovant CEO
Uninformative Buy
―
$19.86M
Immunovant
―
Chief Executive Officer, Director
―
―
List of latest transactions for each holding click on a transaction to see Eric Venker's performance on stock
You May Also Like
Eric Venker insider profile FAQ
What is the percentage of profitable transactions made by Eric Venker?
The percentage of profitable transactions made by Eric Venker is 38%.
What is the average return per transaction made by Eric Venker?
The average return per transaction made by Eric Venker is -18.90%.
What stocks does Eric Venker hold?
Eric Venker holds: ROIV, IMVT stocks.
What was Eric Venker’s latest transaction?
Eric Venker latest transaction was an Uninformative Buy of ―.
What was Eric Venker's most profitable transaction?
Eric Venker’s most profitable transaction was an Informative Sell of ROIV stock on December 31, 2024. The return on the trade was 2.80%.
What is Eric Venker's role in Roivant Sciences?
Eric Venker's role in Roivant Sciences is President & Immunovant CEO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.